CCA
USNA icon

Catalyst Capital Advisors’s Usana Health Sciences USNA Stock Holding History

Catalyst Capital Advisors’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-5,800
Closed -$370K – 637
2015
Q4 		$370K Buy
+5,800
New +$376K 0.05% 210

Other funds holding USNA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NAP
New Amsterdam Partners New York $272M AUM 12.21% 1-Year Est. Return

Catalyst Capital Advisors's USNA Position: Q1 2016 in Review

Catalyst Capital Advisors sold out of Usana Health Sciences (USNA) in Q1 2016, closing a stake of 5,800 shares — an estimated $370K sold.

Catalyst Capital Advisors first reported a position in USNA in Q4 2015 and held it in 1 quarter. The position peaked at $370K in Q4 2015. 136 funds tracked by Wall St. Rank hold USNA as of Q1 2016.

  • Catalyst Capital Advisors reported no remaining Usana Health Sciences position as of Q1 2016 after selling out during the quarter.
  • Catalyst Capital Advisors sold 5,800 Usana Health Sciences shares in Q1 2016, an estimated $370K.
  • Catalyst Capital Advisors first reported a position in Usana Health Sciences in Q4 2015 and held it in 1 quarter.
  • Catalyst Capital Advisors's Usana Health Sciences position peaked at $370K in Q4 2015.
  • 136 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2016.

Based on Catalyst Capital Advisors's 13F filing for Q1 2016, filed 11 May 2016.